Stay updated on Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.

Latest updates to the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page
- ChecktodayChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAn NIH-wide notice about terminology changes appears above the page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study details with a simple access-denied screen.SummaryDifference19%

- Check49 days agoChange DetectedThe revision indicator on the page was updated from v3.6.6 to v3.7.0, signaling a new build of the study page. This reflects a maintenance update rather than a substantive change to the study details or features.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page footer revision label was updated from v3.6.5 to v3.6.6. This signals a small update to the page template or content management system without changing the displayed study details.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.